Download PDF
CC BY-NC-ND 4.0 · Rev Bras Ortop (Sao Paulo) 2022; 57(05): 802-806
DOI: 10.1055/s-0042-1744498
Artigo Original
Oncologia

Treatment of Patients Diagnosed with Giant Cell Tumor of Bone: Experience of a Philanthropic Hospital in the State of Piauí, Brazil[*]

Article in several languages: português | English
Leonardo Telles Alves de Aguiar 
1   Universidade Federal do Piauí, Teresina, PI, Brasil
,
Juliani Barros Moura de Vasconcelos 
2   Associação Piauiense de Combate ao Câncer Alcenor Almeida, Hospital São Marcos, Teresina, PI, Brasil
,
Marcelo Barbosa Ribeiro 
3   Universidade Federal do Piauí, Teresina, PI, Brasil
4   Associação Piauiense de Combate ao Câncer Alcenor Almeida, Hospital São Marcos, Teresina, PI, Brasil
› Author Affiliations Funding Sources The present research did not receive any specific grants from funding agencies in the public, commercial, or non-profit sectors.
› Further Information
   Permissions and Reprints

Abstract

Objective To evaluate the treatment of patients with giant cell tumors of bone treated from 2009 to 2019 in a philanthropic hospital, as well as to try and determine the regional clinical and epidemiological profile, aiming to enrich the Brazilian data set and compare our findings with those of the literature.

Methods An analytical, observational, and cross-sectional study with retrospective data collection and a quantitative approach, analyzing medical records of patients with giant cell tumors treated at a philanthropic hospital from 2009 to 2019.

Results We evaluated 49 medical records; 55.1% of the patients were women, 53.1% were aged between 20 and 40 years, 69.4% of the cases were Campanacci grade III, and 30.6% affected the proximal end of the tibia. The rate of pathological fractures secondary to the tumor and pulmonary metastasis was low. More than 69% of the patients underwent intralesional surgery. Recurrence occurred in 16.3% of the cases.

Conclusion The criteria used for the diagnosis, classification, and treatment at our service followed the standards established by the literature, and they can guide further research and improve local prognosis in the future.

Keywords

giant cell tumors/diagnosis - giant cell tumors/classification - bone neoplasms

* Study conducted at Associação Piauiense de Combate ao Câncer Alcenor Almeida, Hospital São Marcos, Teresina, PI, Brazil.




Publication History

Received: 27 January 2021

Accepted: 20 January 2022

Article published online:
07 July 2022

© 2022. Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • Referências

  • 1 Camargo OP, Croci AT, Oliveira CRG, Baptista AM, Caiero MT, Gianotti MA. Tumor de células gigantes: evolução histórica do seu diagnóstico e tratamento junto ao Instituto de Ortopedia e Traumatologia da FMUSP. Acta Ortop Bras 2001; 9 (04) 46-52
    CrossrefGoogle Scholar
  • 2 Canale ST, Beaty JH. Campbell – Cirurgia Ortopédica. 12ª. ed.. Rio de Janeiro: Elsevier; 2016
    Google Scholar
  • 3 Baptista PRR, Prospero JD, Yonamine ED. Tumor de células gigantes. Rev Bras Ortop 2001; 36 (07) 239-244
    Google Scholar
  • 4 Ribeiro MB. Manual de Ortopedia para Graduação. Teresina, PI: Ed. Universidade Federal do Piauí; 2020
    Google Scholar
  • 5 Jesus-Garcia R, Wajchenberg M, Justino MAP, Korukian M, Yshihara I, Ponte FM. Tumor de células gigantes, análise da invasão articular, fratura patológica, recidiva local e metástase para o pulmão. Rev Bras Ortop 1997; 32 (11) 849-856
    Google Scholar
  • 6 de Carvalho Diniz Ferraz DFCD, Torres Dos Santos CA, Farias Costa VH, Gonçalves Souza AM, Gomes Lima PR. Tumor de células gigantes: análise sobre importância do diagnóstico precoce e perfil epidemiológico. Rev Bras Ortop 2016; 51 (01) 58-62
    CrossrefPubMedGoogle Scholar
  • 7 Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res 2011; 469 (02) 591-599
    CrossrefPubMedGoogle Scholar
  • 8 Manaster BJ, Doyle AJ. Giant cell tumors of bone. Radiol Clin North Am 1993; 31 (02) 299-323
    CrossrefPubMedGoogle Scholar
  • 9 Reckling FW, Gurtler RA, Mantz FA. Recurrent giant-cell tumor of bone in a thirteen-year-old girl. A case report. J Bone Joint Surg Am 1979; 61 (02) 281-285
    CrossrefPubMedGoogle Scholar
  • 10 McGrath PJ. Giant-cell tumour of bone: an analysis of fifty-two cases. J Bone Joint Surg Br 1972; 54 (02) 216-229
    CrossrefPubMedGoogle Scholar
  • 11 Bazan PL, Falco RD, Borri AE, Medina M, Ciccioli NM, Danielle S. The use of denosumab in giant cell tumors in the sacrum. Coluna/Columna 2020; 19 (02) 151-153
    CrossrefGoogle Scholar